Peelaerts, W., Bergkvist, L., George, S., Johnson, M., Meyerdirk, L., Schulz, E., Steiner, J.A., Madaj, Z., Ma, J., Becker, K., Nilsson, K.P.R., Colca, J.R. and Brundin, P. 2020. Inhibiting the mitochondrial pyruvate carrier does not ameliorate synucleinopathy in the absence of inflammation or metabolic deficits. Free Neuropathology. 1, (Nov. 2020), 33. DOI:https://doi.org/10.17879/freeneuropathology-2020-3049.